Madrigal Pharmaceuticals (MDGL) Cash Flow Statement

568.570
-8.730-1.51%

Close Dec 8 16:00 ET

568.570
0.0000.00%

Post 18:16 ET

12.91BMarket Cap-44.04P/E (TTM)

Madrigal Pharmaceuticals (MDGL) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

219.21%79.85M

65.13%-47.05M

40.40%-88.89M

-40.51%-455.57M

-30.72%-104.49M

21.12%-66.98M

-79.19%-134.95M

-77.43%-149.16M

-44.19%-324.23M

-36.60%-79.93M

Net income from continuing operations

-6.76%-114.19M

72.18%-42.28M

50.36%-73.24M

-24.69%-465.89M

47.04%-59.42M

-8.33%-106.96M

-77.12%-151.97M

-91.87%-147.54M

-26.50%-373.63M

-30.60%-112.19M

Depreciation and amortization

20.13%358K

41.20%377K

125.60%379K

107.97%1.1M

155.63%363K

120.74%298K

111.90%267K

35.48%168K

12.85%527K

10.08%142K

Other non cash items

6,945.45%1.55M

189.83%1.37M

-24.89%492K

-30.03%1.69M

-28.29%540K

-96.74%22K

-14.80%472K

51.27%655K

202.89%2.41M

146.08%753K

Change In working capital

649.48%163.1M

-290.23%-31.68M

-67.65%-37.46M

-2,108.33%-72.35M

-485.42%-63.65M

6,100.00%21.76M

-597.94%-8.12M

-17.72%-22.34M

-108.71%-3.28M

-12.50%16.51M

-Change in receivables

-44.52%-34.05M

-158.05%-17.8M

---7.61M

---53.82M

---23.36M

---23.56M

---6.9M

--0

-Change in inventory

-254.23%-5.82M

-32.78%-8.26M

-2,379.27%-21.17M

---34.07M

---25.35M

---1.64M

---6.22M

---854K

--0

-Change in prepaid assets

257.26%9.28M

-3,710.56%-35.36M

13.13%-9.46M

-1,816.40%-10.64M

22,209.38%7.08M

-10,096.61%-5.9M

32.26%-928K

-1,481.35%-10.89M

55.85%-555K

-102.42%-32K

-Change in payables and accrued expense

266.39%193.7M

401.79%29.75M

107.36%780K

1,062.18%26.18M

-233.04%-22.01M

18,005.14%52.87M

2,763.77%5.93M

46.36%-10.6M

-107.00%-2.72M

-5.71%16.55M

Cash from discontinued investing activities

Operating cash flow

219.21%79.85M

65.13%-47.05M

40.40%-88.89M

-40.51%-455.57M

-30.72%-104.49M

21.12%-66.98M

-79.19%-134.95M

-77.43%-149.16M

-44.19%-324.23M

-36.60%-79.93M

Investing cash flow

Cash flow from continuing investing activities

-2.28%-207M

139.20%47.86M

67.13%163.88M

45.40%-274.39M

86.76%-47.95M

-503.18%-202.39M

-3,171.65%-122.1M

152.47%98.05M

-343.13%-502.52M

-645.47%-362.12M

Net PPE purchase and sale

-10.01%-857K

--0

1.15%-1.46M

81.18%-195K

-129.79%-779K

-89.86%-131K

-920.00%-357K

-581.57%-1.48M

-3,472.41%-1.04M

Net intangibles purchase and sale

---3M

--0

---5M

--0

---5M

--0

Net investment purchase and sale

-0.76%-203.14M

140.92%47.86M

66.53%163.88M

46.53%-267.92M

86.77%-47.76M

-498.93%-201.61M

-3,093.20%-116.97M

152.67%98.41M

-342.16%-501.04M

-643.67%-361.09M

Cash from discontinued investing activities

Investing cash flow

-2.28%-207M

139.20%47.86M

67.13%163.88M

45.40%-274.39M

86.76%-47.95M

-503.18%-202.39M

-3,171.65%-122.1M

152.47%98.05M

-343.13%-502.52M

-645.47%-362.12M

Financing cash flow

Cash flow from continuing financing activities

3,071.36%236.65M

-98.70%1.74M

-98.49%8.64M

23.52%735.06M

-95.88%19.77M

-61.89%7.46M

212.42%134.12M

988.83%573.71M

89.86%595.12M

81.55%479.92M

Net issuance payments of debt

----

--0

30.00%65M

--0

Net common stock issuance

--0

-110.05%-8.64M

-97.23%8.64M

52.77%397.49M

-100.01%-23K

--0

295.10%85.95M

--311.56M

1.88%260.19M

-7.71%235.7M

Proceeds from stock option exercised by employees

137.67%17.74M

-78.45%10.38M

--0

24.89%337.58M

-91.89%19.79M

287.64%7.46M

670.66%48.17M

1,364.25%262.15M

2,918.34%270.29M

2,627.11%244.21M

Net other financing activities

----

59.03%-363K

--0

Cash from discontinued financing activities

Financing cash flow

3,071.36%236.65M

-98.70%1.74M

-98.49%8.64M

23.52%735.06M

-95.88%19.77M

-61.89%7.46M

212.42%134.12M

988.83%573.71M

89.86%595.12M

81.55%479.92M

Net cash flow

Beginning cash position

-61.73%191.19M

-69.70%188.65M

5.11%105.02M

-69.86%99.92M

283.02%237.68M

547.18%499.6M

449.40%622.52M

-69.86%99.92M

814.14%331.55M

4.58%62.06M

Current changes in cash

141.81%109.5M

102.07%2.55M

-84.00%83.63M

102.20%5.1M

-450.41%-132.67M

-1,629.83%-261.91M

-240.39%-122.92M

339.46%522.6M

-178.45%-231.63M

-86.09%37.86M

End cash Position

26.51%300.69M

-61.73%191.19M

-69.70%188.65M

5.11%105.02M

283.02%237.68M

547.18%499.6M

449.40%622.52M

-69.86%99.92M

Free cash flow

212.15%75.99M

66.41%-47.05M

40.55%-88.89M

-41.85%-462.03M

-29.29%-104.68M

20.52%-67.76M

-85.83%-140.08M

-77.78%-149.51M

-44.71%-325.71M

-38.30%-80.97M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	219.21%79.85M	65.13%-47.05M	40.40%-88.89M	-40.51%-455.57M	-30.72%-104.49M	21.12%-66.98M	-79.19%-134.95M	-77.43%-149.16M	-44.19%-324.23M	-36.60%-79.93M
Net income from continuing operations	-6.76%-114.19M	72.18%-42.28M	50.36%-73.24M	-24.69%-465.89M	47.04%-59.42M	-8.33%-106.96M	-77.12%-151.97M	-91.87%-147.54M	-26.50%-373.63M	-30.60%-112.19M
Depreciation and amortization	20.13%358K	41.20%377K	125.60%379K	107.97%1.1M	155.63%363K	120.74%298K	111.90%267K	35.48%168K	12.85%527K	10.08%142K
Other non cash items	6,945.45%1.55M	189.83%1.37M	-24.89%492K	-30.03%1.69M	-28.29%540K	-96.74%22K	-14.80%472K	51.27%655K	202.89%2.41M	146.08%753K
Change In working capital	649.48%163.1M	-290.23%-31.68M	-67.65%-37.46M	-2,108.33%-72.35M	-485.42%-63.65M	6,100.00%21.76M	-597.94%-8.12M	-17.72%-22.34M	-108.71%-3.28M	-12.50%16.51M
-Change in receivables	-44.52%-34.05M	-158.05%-17.8M	---7.61M	---53.82M	---23.36M	---23.56M	---6.9M	--0	--0	--0
-Change in inventory	-254.23%-5.82M	-32.78%-8.26M	-2,379.27%-21.17M	---34.07M	---25.35M	---1.64M	---6.22M	---854K	--0	--0
-Change in prepaid assets	257.26%9.28M	-3,710.56%-35.36M	13.13%-9.46M	-1,816.40%-10.64M	22,209.38%7.08M	-10,096.61%-5.9M	32.26%-928K	-1,481.35%-10.89M	55.85%-555K	-102.42%-32K
-Change in payables and accrued expense	266.39%193.7M	401.79%29.75M	107.36%780K	1,062.18%26.18M	-233.04%-22.01M	18,005.14%52.87M	2,763.77%5.93M	46.36%-10.6M	-107.00%-2.72M	-5.71%16.55M
Cash from discontinued investing activities
Operating cash flow	219.21%79.85M	65.13%-47.05M	40.40%-88.89M	-40.51%-455.57M	-30.72%-104.49M	21.12%-66.98M	-79.19%-134.95M	-77.43%-149.16M	-44.19%-324.23M	-36.60%-79.93M
Investing cash flow
Cash flow from continuing investing activities	-2.28%-207M	139.20%47.86M	67.13%163.88M	45.40%-274.39M	86.76%-47.95M	-503.18%-202.39M	-3,171.65%-122.1M	152.47%98.05M	-343.13%-502.52M	-645.47%-362.12M
Net PPE purchase and sale	-10.01%-857K	--0	--0	1.15%-1.46M	81.18%-195K	-129.79%-779K	-89.86%-131K	-920.00%-357K	-581.57%-1.48M	-3,472.41%-1.04M
Net intangibles purchase and sale	---3M	--0	--0	---5M	--0	--0	---5M	--0	--0	--0
Net investment purchase and sale	-0.76%-203.14M	140.92%47.86M	66.53%163.88M	46.53%-267.92M	86.77%-47.76M	-498.93%-201.61M	-3,093.20%-116.97M	152.67%98.41M	-342.16%-501.04M	-643.67%-361.09M
Cash from discontinued investing activities
Investing cash flow	-2.28%-207M	139.20%47.86M	67.13%163.88M	45.40%-274.39M	86.76%-47.95M	-503.18%-202.39M	-3,171.65%-122.1M	152.47%98.05M	-343.13%-502.52M	-645.47%-362.12M
Financing cash flow
Cash flow from continuing financing activities	3,071.36%236.65M	-98.70%1.74M	-98.49%8.64M	23.52%735.06M	-95.88%19.77M	-61.89%7.46M	212.42%134.12M	988.83%573.71M	89.86%595.12M	81.55%479.92M
Net issuance payments of debt	----	----	----	--0	--0	--0	--0	--0	30.00%65M	--0
Net common stock issuance	--0	-110.05%-8.64M	-97.23%8.64M	52.77%397.49M	-100.01%-23K	--0	295.10%85.95M	--311.56M	1.88%260.19M	-7.71%235.7M
Proceeds from stock option exercised by employees	137.67%17.74M	-78.45%10.38M	--0	24.89%337.58M	-91.89%19.79M	287.64%7.46M	670.66%48.17M	1,364.25%262.15M	2,918.34%270.29M	2,627.11%244.21M
Net other financing activities	----	----	----	----	----	----	----	----	59.03%-363K	--0
Cash from discontinued financing activities
Financing cash flow	3,071.36%236.65M	-98.70%1.74M	-98.49%8.64M	23.52%735.06M	-95.88%19.77M	-61.89%7.46M	212.42%134.12M	988.83%573.71M	89.86%595.12M	81.55%479.92M
Net cash flow
Beginning cash position	-61.73%191.19M	-69.70%188.65M	5.11%105.02M	-69.86%99.92M	283.02%237.68M	547.18%499.6M	449.40%622.52M	-69.86%99.92M	814.14%331.55M	4.58%62.06M
Current changes in cash	141.81%109.5M	102.07%2.55M	-84.00%83.63M	102.20%5.1M	-450.41%-132.67M	-1,629.83%-261.91M	-240.39%-122.92M	339.46%522.6M	-178.45%-231.63M	-86.09%37.86M
End cash Position	26.51%300.69M	-61.73%191.19M	-69.70%188.65M	5.11%105.02M	5.11%105.02M	283.02%237.68M	547.18%499.6M	449.40%622.52M	-69.86%99.92M	-69.86%99.92M
Free cash flow	212.15%75.99M	66.41%-47.05M	40.55%-88.89M	-41.85%-462.03M	-29.29%-104.68M	20.52%-67.76M	-85.83%-140.08M	-77.78%-149.51M	-44.71%-325.71M	-38.30%-80.97M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"